VFA
Values First Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,844
| Closed | -$988K | – | 168 |
|
|
2023
Q4 | $988K | Sell |
7,844
-2,391
| -23% | -$301K | 0.6% | 50 |
|
|
2023
Q3 | $958K | Buy |
10,235
+314
| +3% | +$29.4K | 0.62% | 48 |
|
|
2023
Q2 | $885K | Buy |
9,921
+2,517
| +34% | +$225K | 0.53% | 53 |
|
|
2023
Q1 | $794K | Buy |
7,404
+150
| +2% | +$16.1K | 0.51% | 57 |
|
|
2022
Q4 | $886K | Sell |
7,254
-1,973
| -21% | -$241K | 0.62% | 50 |
|
|
2022
Q3 | $953K | Sell |
9,227
-3,302
| -26% | -$341K | 0.68% | 49 |
|
|
2022
Q2 | $1.17M | Sell |
12,529
-1,536
| -11% | -$143K | 0.83% | 39 |
|
|
2022
Q1 | $1.65M | Buy |
14,065
+4,056
| +41% | +$476K | 1.04% | 32 |
|
|
2021
Q4 | $1.35M | Sell |
10,009
-3,859
| -28% | -$519K | 0.8% | 40 |
|
|
2021
Q3 | $2.21M | Buy |
13,868
+2,877
| +26% | +$458K | 1.43% | 20 |
|
|
2021
Q2 | $1.45M | Buy |
10,991
+652
| +6% | +$85.8K | 0.98% | 37 |
|
|
2021
Q1 | $1.33M | Buy |
10,339
+2,023
| +24% | +$261K | 0.98% | 37 |
|
|
2020
Q4 | $1.39M | Buy |
8,316
+755
| +10% | +$126K | 1.11% | 34 |
|
|
2020
Q3 | $1.17M | Sell |
7,561
-228
| -3% | -$35.2K | 1.07% | 32 |
|
|
2020
Q2 | $1.15M | Sell |
7,789
-539
| -6% | -$79.7K | 1.14% | 33 |
|
|
2020
Q1 | $938K | Sell |
8,328
-1,995
| -19% | -$225K | 1.13% | 39 |
|
|
2019
Q4 | $1.44M | Buy |
+10,323
| New | +$1.44M | 1.39% | 24 |
|